https://www.mskcc.org/cancer-care/clinical-trials/23-020
A Phase 1/2 Study of BGB-11417 Given Alone and With Carfilzomib and/or Dexamethasone to Treat...
Full Title A Study of BGB-11417 Given Alone and in Combination With Carfilzomib and/or Dexamethasone, Dexamethasone/Daratumumab, and Dexamethasone/Pomalidomide...
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carfilzomib
Definition of carfilzomib - NCI Drug Dictionary - NCI
Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes...
definition ofcarfilzomibncidrugdictionary
https://www.mayo.edu/research/clinical-trials/cls-20566961
Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or...
Learn more about services at Mayo Clinic.
https://medlineplus.gov/druginfo/meds/a612031.html
Carfilzomib Injection: MedlinePlus Drug Information
Carfilzomib Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus
carfilzomibinjectionmedlineplusdruginformation
https://www.mayo.edu/research/clinical-trials/cls-20457165
A Study To Evaluate CB-839 HCl In Combination With Carfilzomib And Dexamethasone In Treating...
Learn more about services at Mayo Clinic.
https://www.ncbi.nlm.nih.gov/Structure/pdb/4QW4
4QW4: yCP in complex with carfilzomib
Probable proteasome subunit alpha type-7Proteasome subunit alpha type-1Proteasome subunit alpha type-2Proteasome subunit alpha type-3Proteasome subunit alpha...
ycpcomplexcarfilzomib
https://www.hmpgloballearningnetwork.com/site/onc/news/maintenance-carfilzomib-plus-lenalidomide-and-dexamethasone-following-autologous-hsct
Maintenance Carfilzomib Plus Lenalidomide and Dexamethasone Following Autologous HSCT for Newly...
Results from the phase 3 ATLAS trial demonstrate that carfilzomib plus lenalidomide and dexamethasone significantly improves PFS in newly diagnosed patients...
maintenancecarfilzomibpluslenalidomide
https://www.news-medical.net/news/20151211/Role-for-carfilzomib-in-relapsed-refractory-multiple-myeloma-treatment.aspx
Role for carfilzomib in relapsed, refractory multiple myeloma treatment
Dec 11, 2015 - Carfilzomib significantly improves outcomes in previously treated patients with relapsed or refractory multiple myeloma, shows a head-to-head comparison with...
multiple myelomarolecarfilzomibrelapsedrefractory
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT04268498&r=1
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of Newly Diagnosed...
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of Newly Diagnosed Multiple Myeloma
for thedaratumumabcarfilzomiblenalidomidedexamethasone
https://www.rcsb.org/structure/4QWG
RCSB PDB - 4QWG: yCP beta5-A49V mutant in complex with carfilzomib
yCP beta5-A49V mutant in complex with carfilzomib
rcsb pdbycp
https://www.prweb.com/releases/tragara_reports_interim_results_of_phase_1b_study_of_tg02_and_carfilzomib_in_multiple_myeloma/prweb12376938.htm
Tragara Reports Interim Results of Phase 1b Study of TG02 and Carfilzomib in Multiple Myeloma
San Diego, California (PRWEB) December 06, 2014 -- Tragara Pharmaceuticals, Inc. today reported early clinical observations from an ongoing Phase 1b trial of...
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-carfilzomib-myeloma-muk5
A trial looking at carfilzomib for myeloma (MUK 5)
This trial looked at combining carfilzomib with cyclophosphamide and dexamethasone to treat myeloma.
a triallooking atcarfilzomibmyelomamuk
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT01863550&r=1
Bortezomib or Carfilzomib with Lenalidomide and Dexamethasone in Treating Patients with Newly...
Bortezomib or Carfilzomib with Lenalidomide and Dexamethasone in Treating Patients with Newly Diagnosed Multiple Myeloma
bortezomibcarfilzomiblenalidomide
https://www.ncbi.nlm.nih.gov/Structure/pdb/5D0V
5D0V: Yeast 20S proteasome beta5-T1C mutant in complex with Carfilzomib
Probable proteasome subunit alpha type-7Proteasome subunit alpha type-1Proteasome subunit alpha type-2Proteasome subunit alpha type-3Proteasome subunit alpha...
20s proteasomeyeast
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-comparing-carfilzomib-once-a-week-with-carfilzomib-twice-a-week-for-myeloma-arrow
A trial comparing carfilzomib once a week with carfilzomib twice a week for myeloma (ARROW)
This trial looked at different ways to have carfilzomib for people with myeloma that had come back or treatment had stopped working.
a trialcomparingcarfilzomib
https://www.rcsb.org/structure/4QWS
RCSB PDB - 4QWS: yCP beta5-C63F mutant in complex with carfilzomib
yCP beta5-C63F mutant in complex with carfilzomib
rcsb pdbycp
https://www.cigna.com/knowledge-center/hw/medications/carfilzomib-injection-a612031
Carfilzomib Injection | Cigna
carfilzomibinjectioncigna
https://www.einpresswire.com/article/815214815/linvoseltamab-in-combination-with-carfilzomib-or-bortezomib-shows-promising-initial-results-in-earlier-lines-of-treatment-for-relapsed-refractory
Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial Results in...
May 22, 2025 - Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced initial results from two cohorts of the Phase 1b LINKER-MM2 trial evaluating linvoseltamab in
linvoseltamabcombinationcarfilzomib
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/carfilzomib
Definition of carfilzomib - NCI Dictionary of Cancer Terms - NCI
NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine.
definition ofcarfilzomibncidictionarycancer